Glenmede Trust’s Viridian Therapeutics VRDN Stock Holding History

Glenmede Trust’s Portfolio VRDN Stock Details VRDN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$480K	Buy
2023 Q3	–	Sell
2023 Q2	$342K	Hold
2023 Q1	$342K	Buy
2022 Q4	$241K	Buy
2017 Q4	–	Sell
2017 Q3	$16K	Buy